5. JG Shi et al. The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers. J Clin Pharmacol 2011 May 20 [Epub ahead of print].
6. Wholesale acquisition cost (WAC) of 60 tablets. Source: PricePointRx.™ Reprinted with permission by FDB, Inc. All rights reserved. © 2012. http://www.firstdatabank.com/Support/drug-pricing-policy.aspx. Accessed March 23, 2012.